Literature DB >> 16728760

The Philip Morris External Research Program: results from the first round of projects.

N Hirschhorn1, S Aguinaga Bialous, S Shatenstein.   

Abstract

BACKGROUND: Philip Morris (PM) launched the Philip Morris External Research Program (PMERP) in 2000, two years after the company agreed to the dissolution of two industry-wide, external research programmes: the Council for Tobacco Research (CTR) and the Center for Indoor Air Research (CIAR). Our previous analysis of PMERP's Request for Applications noted that PMERP's structure, while ostensibly concerned with new product development, was remarkably similar to that of CIAR. We also found the majority of designated peer-reviewers had previous ties to the tobacco industry and the research solicitation seemed to invite mitigating evidence concerning cigarettes and constituent risks. We concluded that a prime reason for PMERP's existence was to garner scientific credibility for PM.
OBJECTIVE: To examine the grants awarded in the first round of PMERP and subsequent peer-reviewed publications.
METHODS: Searches of industry documents available on the internet using PMERP and its variations as initial keywords; searches on Medline for publications from PMERP grantees.
RESULTS: Of 153 applications, 61 proposals were funded, 36 of which generated 78 scientific publications. Of these, 65% deal specifically with the tobacco plant or constituents. Over half the researchers listed as PMERP participants had previously received or applied for tobacco funding. One internal document indicated PMERP's objectives included gaining "credibility" and "goodwill", and finding "young scientists". In addition, PM has launched its own and more extensive internal product design research programme.
CONCLUSION: PMERP appears to exist less as a conduit for critical scientific inquiry than to fit into a corporate strategy intended to burnish PM's public image.

Entities:  

Mesh:

Year:  2006        PMID: 16728760      PMCID: PMC2564674          DOI: 10.1136/tc.2005.012799

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  8 in total

1.  The ethics of the cash register: taking tobacco research dollars.

Authors:  S Chapman; S Shatenstein
Journal:  Tob Control       Date:  2001-03       Impact factor: 7.552

Review 2.  Review of the quality of studies on the economic effects of smoke-free policies on the hospitality industry.

Authors:  M Scollo; A Lal; A Hyland; S Glantz
Journal:  Tob Control       Date:  2003-03       Impact factor: 7.552

3.  Chasing the dollar: why scientists should decline tobacco industry funding.

Authors:  R E Malone; L A Bero
Journal:  J Epidemiol Community Health       Date:  2003-08       Impact factor: 3.710

4.  Ethics. Is tobacco research turning over a new leaf?

Authors:  David Grimm
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

5.  Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research.

Authors:  D E Barnes; L A Bero
Journal:  J Health Polit Policy Law       Date:  1996       Impact factor: 2.265

Review 6.  The limits of competing interest disclosures.

Authors:  L A Bero; S Glantz; M-K Hong
Journal:  Tob Control       Date:  2005-04       Impact factor: 7.552

7.  Philip Morris' new scientific initiative: an analysis.

Authors:  N Hirschhorn; S A Bialous; S Shatenstein
Journal:  Tob Control       Date:  2001-09       Impact factor: 7.552

8.  Corporate social responsibility and the tobacco industry: hope or hype?

Authors:  N Hirschhorn
Journal:  Tob Control       Date:  2004-12       Impact factor: 7.552

  8 in total
  4 in total

Review 1.  Old ways, new means: tobacco industry funding of academic and private sector scientists since the Master Settlement Agreement.

Authors:  Suzaynn F Schick; Stanton A Glantz
Journal:  Tob Control       Date:  2007-06       Impact factor: 7.552

2.  Criteria for evaluating tobacco control research funding programs and their application to models that include financial support from the tobacco industry.

Authors:  J E Cohen; M Zeller; T Eissenberg; M Parascandola; R O'Keefe; L Planinac; S Leischow
Journal:  Tob Control       Date:  2009-02-24       Impact factor: 7.552

3.  Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.

Authors:  Crystal E Tan; Thomas Kyriss; Stanton A Glantz
Journal:  PLoS Med       Date:  2013-05-28       Impact factor: 11.069

4.  "A good personal scientific relationship": Philip Morris scientists and the Chulabhorn Research Institute, Bangkok.

Authors:  Ross Mackenzie; Jeff Collin
Journal:  PLoS Med       Date:  2008-12-23       Impact factor: 11.069

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.